TipRanks
CVS Health Corp (CH:CVS)
:CVS
Switzerland Market
CVS
CVS Health
RESEARCH TOOLSreports

CVS Health (CVS) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

CVS Analyst Ratings

Strong Buy
19Ratings
Strong Buy
18 Buy
1 Hold
0 Sell
Based on 19 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CVS Stock 12 Month Forecast

Average Price Target

―
Based on 19 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is CHF93.88 with a high forecast of CHF102.61 and a low forecast of CHF84.55. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF102.61Average Price TargetCHF93.88Lowest Price TargetCHF84.55
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:CVS
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF861.89→CHF98.5
Buy
―
Reiterated
09/15/26
Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (NASDAQ: BNTC), CVS Health (NYSE: CVS) and BioNTech SE (NASDAQ: BNTX)
Wells Fargo Analyst forecast on CH:CVS
Stephen Baxter
Wells Fargo
Wells Fargo
CHF100.96
Buy
―
Reiterated
09/15/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Ascendis Pharma (NASDAQ: ASND) and BridgeBio Oncology Therapeutics (NASDAQ: BBOT)
Bernstein Analyst forecast on CH:CVS
Lance Wilkes
Bernstein
Bernstein
CHF87.01
Buy
―
Assigned
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (NYSE: SYK), CVS Health (NYSE: CVS) and Biogen (NASDAQ: BIIB)
UBS Analyst forecast on CH:CVS
Kevin Caliendo
UBS
UBS
CHF103.43→CHF96.86
Buy
―
Assigned
09/03/26
CVS Health price target lowered to $118 from $126 at UBSCVS Health price target lowered to $118 from $126 at UBS
Jefferies Analyst forecast on CH:CVS
Brian Tanquilut
Jefferies
Jefferies
CHF98.5
Buy
―
Reiterated
08/31/26
CVS Health remains top large cap pick in healthcare services at JefferiesCVS Health remains top large cap pick in healthcare services at Jefferies
TD Cowen Analyst forecast on CH:CVS
Charles Rhyee
TD Cowen
TD Cowen
CHF90.29
Buy
―
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (NASDAQ: SYRE) and CVS Health (NYSE: CVS)
Piper Sandler Analyst forecast on CH:CVS
Jessica Tassan
Piper Sandler
Piper Sandler
CHF92.76
Buy
―
Reiterated
08/26/26
Piper Sandler Remains a Buy on CVS Health (CVS)
Argus Research Analyst forecast on CH:CVS
Steven Silver
Argus Research
Argus Research
CHF85.37→CHF93.58
Buy
―
Reiterated
08/18/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and CVS Health (NYSE: CVS)
J.P. Morgan Analyst forecast on CH:CVS
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF91.11→CHF96.86
Buy
―
Reiterated
08/12/26
J.P. Morgan Remains a Buy on CVS Health (CVS)
Morgan Stanley Analyst forecast on CH:CVS
Erin Wright
Morgan Stanley
Morgan Stanley
CHF91.11
Buy
―
Assigned
08/10/26
Morgan Stanley Keeps Their Buy Rating on CVS Health (CVS)
Truist Financial Analyst forecast on CH:CVS
David S Macdonald
Truist Financial
Truist Financial
CHF96.86
Buy
―
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), CVS Health (NYSE: CVS) and Sarepta Therapeutics (NASDAQ: SRPT)
RBC Capital Analyst forecast on CH:CVS
Ben Hendrix
RBC Capital
RBC Capital
CHF92.76
Buy
―
Reiterated
08/06/26
RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)
Evercore ISI Analyst forecast on CH:CVS
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF106.71→CHF102.61
Buy
―
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on CH:CVS
Michael Ha
Robert W. Baird
Robert W. Baird
CHF77.16→CHF87.83
Buy
―
Reiterated
08/06/26
CVS Health price target raised to $107 from $94 at BairdCVS Health price target raised to $107 from $94 at Baird
Barclays Analyst forecast on CH:CVS
Andrew Mok CFA
Barclays
Barclays
CHF87.01→CHF88.65
Buy
―
Reiterated
08/06/26
Barclays Sticks to Its Buy Rating for CVS Health (CVS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on CH:CVS
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF861.89→CHF98.5
Buy
―
Reiterated
09/15/26
Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (NASDAQ: BNTC), CVS Health (NYSE: CVS) and BioNTech SE (NASDAQ: BNTX)
Wells Fargo Analyst forecast on CH:CVS
Stephen Baxter
Wells Fargo
Wells Fargo
CHF100.96
Buy
―
Reiterated
09/15/26
Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Ascendis Pharma (NASDAQ: ASND) and BridgeBio Oncology Therapeutics (NASDAQ: BBOT)
Bernstein Analyst forecast on CH:CVS
Lance Wilkes
Bernstein
Bernstein
CHF87.01
Buy
―
Assigned
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (NYSE: SYK), CVS Health (NYSE: CVS) and Biogen (NASDAQ: BIIB)
UBS Analyst forecast on CH:CVS
Kevin Caliendo
UBS
UBS
CHF103.43→CHF96.86
Buy
―
Assigned
09/03/26
CVS Health price target lowered to $118 from $126 at UBSCVS Health price target lowered to $118 from $126 at UBS
Jefferies Analyst forecast on CH:CVS
Brian Tanquilut
Jefferies
Jefferies
CHF98.5
Buy
―
Reiterated
08/31/26
CVS Health remains top large cap pick in healthcare services at JefferiesCVS Health remains top large cap pick in healthcare services at Jefferies
TD Cowen Analyst forecast on CH:CVS
Charles Rhyee
TD Cowen
TD Cowen
CHF90.29
Buy
―
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (NASDAQ: SYRE) and CVS Health (NYSE: CVS)
Piper Sandler Analyst forecast on CH:CVS
Jessica Tassan
Piper Sandler
Piper Sandler
CHF92.76
Buy
―
Reiterated
08/26/26
Piper Sandler Remains a Buy on CVS Health (CVS)
Argus Research Analyst forecast on CH:CVS
Steven Silver
Argus Research
Argus Research
CHF85.37→CHF93.58
Buy
―
Reiterated
08/18/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and CVS Health (NYSE: CVS)
J.P. Morgan Analyst forecast on CH:CVS
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF91.11→CHF96.86
Buy
―
Reiterated
08/12/26
J.P. Morgan Remains a Buy on CVS Health (CVS)
Morgan Stanley Analyst forecast on CH:CVS
Erin Wright
Morgan Stanley
Morgan Stanley
CHF91.11
Buy
―
Assigned
08/10/26
Morgan Stanley Keeps Their Buy Rating on CVS Health (CVS)
Truist Financial Analyst forecast on CH:CVS
David S Macdonald
Truist Financial
Truist Financial
CHF96.86
Buy
―
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), CVS Health (NYSE: CVS) and Sarepta Therapeutics (NASDAQ: SRPT)
RBC Capital Analyst forecast on CH:CVS
Ben Hendrix
RBC Capital
RBC Capital
CHF92.76
Buy
―
Reiterated
08/06/26
RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)
Evercore ISI Analyst forecast on CH:CVS
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF106.71→CHF102.61
Buy
―
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on CH:CVS
Michael Ha
Robert W. Baird
Robert W. Baird
CHF77.16→CHF87.83
Buy
―
Reiterated
08/06/26
CVS Health price target raised to $107 from $94 at BairdCVS Health price target raised to $107 from $94 at Baird
Barclays Analyst forecast on CH:CVS
Andrew Mok CFA
Barclays
Barclays
CHF87.01→CHF88.65
Buy
―
Reiterated
08/06/26
Barclays Sticks to Its Buy Rating for CVS Health (CVS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTVTvTv Therapeutics
MDWDMediwound
AXGNAxoGen
SIBNSI-Bone
LGNDLigand Pharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

3 Months
Stephen BaxterWells Fargo
Success Rate
14/20 ratings generated profit
70%
Average Return
+11.08%
Copying Stephen Baxter's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +11.08% per trade.
1 Year
Stephen BaxterWells Fargo
Success Rate
16/20 ratings generated profit
80%
Average Return
+24.19%
Copying Stephen Baxter's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +24.19% per trade.
2 Years
Allen LutzBank of America Securities
Success Rate
24/28 ratings generated profit
86%
Average Return
+28.70%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +28.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CVS Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
33
34
37
36
35
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
34
38
37
36
In the current month, CVS has received 35 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 93.88.
Each month's total comprises the sum of three months' worth of ratings.

CVS Financial Forecast

CVS Earnings Forecast

Next quarter’s earnings estimate for CVS is CHF1.35 with a range of CHF1.20 to CHF1.59. The previous quarter’s EPS was CHF2.12. CVS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.
Next quarter’s earnings estimate for CVS is CHF1.35 with a range of CHF1.20 to CHF1.59. The previous quarter’s EPS was CHF2.12. CVS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.

CVS Sales Forecast

Next quarter’s sales forecast for CVS is CHF85.77B with a range of CHF84.01B to CHF89.16B. The previous quarter’s sales results were CHF87.10B. CVS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.
Next quarter’s sales forecast for CVS is CHF85.77B with a range of CHF84.01B to CHF89.16B. The previous quarter’s sales results were CHF87.10B. CVS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.

CVS Stock Forecast FAQ

What is CH:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 93.88.
    What is CH:CVS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CVS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CVS Health Corp a Buy, Sell or Hold?
        CVS Health Corp has a consensus rating of Strong Buy, which is based on 18 buy ratings, 1 hold ratings and 0 sell ratings.
          What is CVS Health Corp’s share price target?
          The average share price target for CVS Health Corp is 93.88. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF102.61 ,and the lowest forecast is CHF84.55. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about CVS Health Corp?
            CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
              How can I buy shares of CVS Health Corp?
              To buy shares of CH:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.